Chronic sinusitis with nasal polyps (CRSwNP) accounts for 20 to 33 percent of these cases. Even after surgical treatment, the recurrence rate of CRSwNP remains high, ranging from 20 to 60 percent ...
AZ is hoping that Fasenra (benralizumab) could join rival drugs from Sanofi/Regeneron and GlaxoSmithKline as approved therapies for chronic rhinosinusitis with nasal polyps (CRSwNP) that have been ...
After hours: March 12 at 7:59:25 PM EDT Loading Chart for ICON ...
In this guide, we review the top ICO cryptos for 2025 and share our methodology for selecting standout ICOs. What Is a Crypto ICO? A crypto Initial Coin Offering (ICO) is a fundraising method for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
